Summary:
Symbiotec Pharmalab IPO allotment is scheduled to be finalised on August 28, 2026, after the ₹1,757 crore issue was subscribed 14.59 times overall. Investors can check their allotment status through the BSE, NSE or MUFG Intime India website using their PAN, application number or Demat details. Shares are expected to be credited by August 31, with listing scheduled for September 1, 2026.
Symbiotec Pharmalab's ₹1,757 crore IPO closed for subscription on August 27, 2026, after being subscribed 14.59 times overall — Non-Institutional Investors led demand at 39.61 times, while retail investors subscribed 8.65 times. With allotment scheduled for finalisation on August 28, 2026, here's a complete guide to checking your allotment status and what comes next.
About Symbiotec Pharmalab IPO
Incorporated in 2002 and headquartered in Indore, Symbiotec Pharmalab is a research and development-driven pharmaceutical and biotechnology company with capabilities across organic chemistry, biotechnology, and complex injectables. The company's business spans corticosteroid and steroidal-hormone active pharmaceutical ingredients, along with nutritional ingredients and specialty products, serving both domestic and international regulated and emerging markets. Revenue grew 15% year-on-year to ₹872.26 crore in FY26, with profit after tax rising 14% to ₹109.90 crore.
Symbiotec Pharmalab IPO Issue Details
| Detail | Information |
| Issue Size | ₹1,757 crore (fresh issue ₹150 crore + OFS ₹1,607 crore) |
| Price Band | ₹938–₹988 per share |
| Lot Size | 15 shares |
| Minimum Investment (Retail) | ₹14,820 |
| Face Value | ₹2 per share |
| IPO Open Date | August 24, 2026 |
| IPO Close Date | August 27, 2026 |
| Registrar | MUFG Intime India Pvt Ltd |
| Book-Running Lead Managers | JM Financial, Avendus Capital, Motilal Oswal Investment Advisors, Nomura Financial Advisory |
Check Symbiotec Pharmalab IPO Allotment Status on BSE & NSE Website
Steps to check on BSE website
- Visit the BSE IPO allotment status page (bseindia.com).
- Select "Equity" from the Issue Type dropdown.
- Choose "Symbiotec Pharmalab Limited" from the Issue Name dropdown.
- Enter your Application Number or PAN.
- Complete the verification and click Submit to view your allotment status.
Steps to check on NSE website
- Visit the NSE IPO bid verification page (nseindia.com).
- Select "Equity & SME IPO Bid Details."
- Choose "Symbiotec Pharmalab" from the issue list.
- Enter your PAN or Application Number.
- Click Submit to view the number of shares allotted, if any.
Check Symbiotec Pharmalab IPO Allotment Status via Registrar
- Visit the MUFG Intime India IPO status page.
- Select "Symbiotec Pharmalab Limited" from the dropdown.
- Choose to search by PAN, Application Number, or Demat Account Number.
- Enter the relevant details and click Submit.
- Your allotment status — allotted or not allotted, along with the number of shares — will be displayed on screen.
Symbiotec Pharmalab IPO Subscription Status
| Category | Subscription (x) |
| Qualified Institutional Buyers (QIBs) | 6.27 |
| Non-Institutional Investors (NIIs) | 39.61 |
| Retail Individual Investors (RIIs) | 8.65 |
| Employees | 9.86 |
| Overall | 14.59 |
The issue received bids for 10,14,85,745 shares against 1,31,24,929 shares on offer.
Symbiotec Pharmalab IPO Listing Details
| Event | Date |
| Anchor Bid Date | August 21, 2026 |
| IPO Open Date | August 24, 2026 |
| IPO Close Date | August 27, 2026 |
| Allotment Finalisation | August 28, 2026 |
| Refund/Demat Credit | August 31, 2026 |
| Listing Date | September 1, 2026 |
| Listing Exchanges | BSE, NSE |
What Happens Once Symbiotec Pharmalab IPO Allotment is Out?
Once the basis of allotment is finalised, investors fall into one of two outcomes. If shares are allotted, they will be credited to your demat account by August 31, 2026, and the corresponding amount blocked via UPI mandate or ASBA will be debited from your bank account. If shares are not allotted, the blocked amount will be released back to your account on the same date.
Given the issue was subscribed nearly 15 times overall — and close to 40 times in the Non-Institutional Investor category — investors should keep in mind that applying for a lot does not guarantee allotment in heavily oversubscribed categories; allocation depends on the number of valid applications and applicable allotment rules. With retail subscription at 8.65 times, many retail applicants may not receive shares. Not receiving an allotment doesn't rule out participation altogether — once Symbiotec Pharmalab lists on the exchanges, investors can still buy shares through the regular secondary market. Once shares are credited, they can be tracked and traded from the listing date, September 1, 2026, when Symbiotec Pharmalab shares debut on the BSE and NSE.
